Herein, we reportthe synthesis of [methylpiperazine-11C]brigatinib,and its preclinical evaluation as a PETtracer for imaging EML4–ALK and EGFR mutated NSCLC in femalenu/nu mice carrying subcutaneous xenografts. The gene discussed is ALK; the disease is non-small cell lung carcinoma.